Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
CB Health Ventures manages $150 million of private equity funds focused on investment opportunities in healthcare services, medical information technology, biotechnology and genomics. CB Health Ventures leverages its access to decision-makers at hundreds of healthcare providers and payers to create value for its investors and the owners of its portfolio companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2006 | Aileron Therapeutics | Series A | 7M |
1/2011 | Viridos | Private Equity Round | - |
1/2020 | Gemphire Therapeutics | Private Equity Round | - |
1/2015 | BIOCIUS Life Sciences | Private Equity Round | - |
1/2004 | BioTrove | Series B | 0 |
8/2002 | Asstrodyne TDI | Series B | 10M |
4/2007 | TransMedics | Series D | 0 |
1/2021 | Orionis Biosciences | Private Equity Round | - |
1/2012 | ShapeUp | Private Equity Round | - |
1/2012 | Tetraphase Pharmaceuticals | Private Equity Round | - |
7/2003 | Carefx | Series A | 7.2M |
10/2004 | GeneOhm Sciences | Series C | 12M |
1/2020 | Oculus Health | Private Equity Round | - |
11/2008 | Aventura Software | Venture Round | 1.6M |
2/2003 | Healthcare Management Directions | Venture Round | 8.1M |
1/2004 | TransMedics | Series B | 27.6M |
3/2006 | TransMedics | Series C | 0 |
7/2004 | Intrapace | Series C | 0 |
11/2002 | Skylight Healthcare Systems | Series B | 7.8M |
8/2011 | Pathogenetix | Series B | 4M |
9/2005 | Carefx | Series B | - |
1/2021 | Neosensory | Private Equity Round | - |
3/2018 | Openwater | Seed Round | - |
10/2005 | Carefx | Series B | 12.3M |
10/2006 | Morphotek | Series D | 0 |
7/2004 | Zonare Medical Systems | Series E | 34M |
1/2005 | GeneOhm Sciences | Series C | 0 |
2/2004 | Morphotek | Series C | 26M |
3/2010 | TransMedics | Series E | 0 |
11/1999 | Passport Health Communications | Series A | 7M |
1/2017 | ClearDATA | Private Equity Round | - |
10/2002 | BioTrove | Private Equity Round | 5.3M |
1/2014 | Qstream | Private Equity Round | - |
7/2005 | BioTrove | Series B | 0 |
11/2011 | Pathogenetix | Series B | 7.5M |
7/2008 | Pathogenetix | Series A | 4.4M |
8/2001 | Morphotek | Series B | 0 |
1/2014 | N-of-One | Private Equity Round | - |
7/2002 | Wellpartner | Series A | - |
6/2004 | CareMedic Systems | Series E | 19.9M |
1/2017 | InfoBionic | Private Equity Round | 6M |
7/2010 | MedVentive | Series C | 2.8M |
2/2000 | Asstrodyne TDI | Series A | 4M |
8/2010 | Activate Networks | Series A | 5M |
1/2012 | nanoMR | Private Equity Round | - |
1/2021 | Orionis Biosciences | Private Equity Round | - |
1/2021 | Neosensory | Private Equity Round | - |
1/2020 | Gemphire Therapeutics | Private Equity Round | - |
1/2020 | Oculus Health | Private Equity Round | - |
3/2018 | Openwater | Seed Round | - |
1/2017 | InfoBionic | Private Equity Round | 0 |
1/2017 | ClearDATA | Private Equity Round | - |
1/2015 | BIOCIUS Life Sciences | Private Equity Round | - |
1/2014 | N-of-One | Private Equity Round | - |
1/2014 | Qstream | Private Equity Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|